Global and United States Genome (DNA) Sequencing Market Report & Forecast 2024-2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global and United States Genome (DNA) Sequencing Market Report & Forecast 2024-2034
Genome (DNA) sequencing is a method that allows several DNA strands to be sequenced simultaneously. Genome sequencing technology aids in the sequencing of an organism's whole genome in order to determine the order or sequence of DNA nucleotides or bases coded with letters including As, Gs, Cs, and Ts. Genome sequencing methods made it feasible to investigate genetics, biomarkers, forensics, customized medicine, and other fields. This technology aids in the transition from traditional procedures to customized medications with the use of genetics. It is a widely utilized method for whole-genome sequencing.
Market Analysis and InsightsGlobal and United States Genome (DNA) Sequencing Market
This report focuses on global and United States Genome (DNA) Sequencing market, also covers the segmentation data of other regions in regional level and county level.
The global Genome (DNA) Sequencing revenue was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the review period (2023-2033).
In United States the Genome (DNA) Sequencing revenue is expected to grow from US$ million in 2022 to US$ million by 2033, at a CAGR of % during the forecast period 2023-2033.
The global key players of Genome (DNA) Sequencing include Agilent Technologies Inc., BGI, Bio-Rad Laboratories, Danaher, F. Hoffmann-La Roche Ltd., Genome Electric Company, Illumina Inc., IntegraGen and Oxford Nanopore Technologies, etc. The global five biggest players hold a share of % in 2022.
Global Genome (DNA) Sequencing Scope and Market Size
Genome (DNA) Sequencing market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Genome (DNA) Sequencing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For United States market, this report focuses on the Genome (DNA) Sequencing market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in United States.
Agilent Technologies Inc.
BGI
Bio-Rad Laboratories
Danaher
F. Hoffmann-La Roche Ltd.
Genome Electric Company
Illumina Inc.
IntegraGen
Oxford Nanopore Technologies
Pacific Biosciences of California Inc.
QIAGEN
Thermo Fisher Scientific Inc.
Segment by Type
Next-Generation Sequencing
Third Generation DNA Sequencing
Others
Research Institutes
Pharmaceutical & Biotechnological Companies
Healthcare Facilities & Diagnostic Centres
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter 1Introduces Genome (DNA) Sequencing definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Genome (DNA) Sequencing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Genome (DNA) Sequencing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Genome (DNA) Sequencing revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions
Market Analysis and InsightsGlobal and United States Genome (DNA) Sequencing Market
This report focuses on global and United States Genome (DNA) Sequencing market, also covers the segmentation data of other regions in regional level and county level.
The global Genome (DNA) Sequencing revenue was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the review period (2023-2033).
In United States the Genome (DNA) Sequencing revenue is expected to grow from US$ million in 2022 to US$ million by 2033, at a CAGR of % during the forecast period 2023-2033.
The global key players of Genome (DNA) Sequencing include Agilent Technologies Inc., BGI, Bio-Rad Laboratories, Danaher, F. Hoffmann-La Roche Ltd., Genome Electric Company, Illumina Inc., IntegraGen and Oxford Nanopore Technologies, etc. The global five biggest players hold a share of % in 2022.
Global Genome (DNA) Sequencing Scope and Market Size
Genome (DNA) Sequencing market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Genome (DNA) Sequencing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For United States market, this report focuses on the Genome (DNA) Sequencing market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in United States.
By Company
Agilent Technologies Inc.
BGI
Bio-Rad Laboratories
Danaher
F. Hoffmann-La Roche Ltd.
Genome Electric Company
Illumina Inc.
IntegraGen
Oxford Nanopore Technologies
Pacific Biosciences of California Inc.
QIAGEN
Thermo Fisher Scientific Inc.
Segment by Type
Next-Generation Sequencing
Third Generation DNA Sequencing
Others
Segment by Application
Research Institutes
Pharmaceutical & Biotechnological Companies
Healthcare Facilities & Diagnostic Centres
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter Introduction
Chapter 1Introduces Genome (DNA) Sequencing definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Genome (DNA) Sequencing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Genome (DNA) Sequencing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Genome (DNA) Sequencing revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices